Overview

* Accuray fiscal Q1 2026 rev down 7% yr/yr, but beats analysts' expectations

* Net loss widens significantly from prior year

* Company initiated restructuring plan, incurring $2.8 mln in charges

Outlook

* Accuray ( ARAY ) reaffirms fiscal 2026 revenue guidance of $471 mln to $485 mln

* Accuray ( ARAY ) expects fiscal 2026 adjusted EBITDA of $31 mln to $35 mln

* Company focuses on strategic transformation and restructuring for future growth

Result Drivers

* RESTRUCTURING PLAN - Co initiated restructuring to reduce costs and streamline operations, incurring $2.8 mln in charges

* SERVICE REVENUE INCREASE - Service revenue grew 7% yr/yr, offsetting decline in product revenue

* PRODUCT INTRODUCTION - Introduction of Accuray Stellar Solution in U.S. market seen as growth opportunity

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q1 Beat $93.94 $92.20

Revenue mln mln (3

Analysts

)

Q1 Net -$21.68

Income mln

Q1 Basic -$0.18

EPS

Q1 Gross $26.55

Profit mln

Q1 -$11.31

Income mln

From

Operatio

ns

Q1 $37.86

Operatin mln

g

Expenses

Analyst Coverage

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

* Wall Street's median 12-month price target for Accuray Inc ( ARAY ) is $4.75, about 70.9% above its November 4 closing price of $1.38

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)